Available Clinical Trials

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355). E-mail: askroswell@roswellpark.org
 

A Phase 1 Study of ASP3082 in Participants with Previously Treated Locally Advanced or Metastatic Solid Tumor Malignancies with KRAS G12D Mutation

Principal Investigator: Fountzilas, Christos

Medical Access Program for Patritumab Deruxtecan (HER3-DXd, U3-1402)

Principal Investigator: Dy, Grace K

Endobronchial Ultrasound Transbronchial Needle guided Interstitial Photodynamic Therapy for Palliation of Locally Advanced Lung Cancer and Advanced Cancers Obstructing the Airway -Phase I/II Study

Principal Investigator: Ivanick, Nathaniel M

A Phase 1 dose-escalation and expansion study to assess safety and preliminary antitumor activity of Debio 0123 in combination with carboplatin and etoposide in adult participants with small cell lung cancer that recurred or progressed after previous…

Principal Investigator: Jain, Prantesh

A Phase 1 study of JNJ-86974680, an A2a receptor antagonist, administered as monotherapy and in combination with cetrelimab and radiotherapy for advanced non-small cell lung cancer

Principal Investigator: Jain, Prantesh

Phase 1/1b, Multicenter, Open-Label, Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects with Advanced KRASG12C Mutant Solid Tumors

Principal Investigator: Yau, Edwin H

(LUNGMAP) A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (LungMAP Screening Study)

Principal Investigator: Yau, Edwin H

Utilizing Patient Reported Quality of Life to Inform Patient Decision Making In Early Stage Lung Cancer

Principal Investigator: Singh, Anurag K

METFORMIN FOR CHEMOPREVENTION OF LUNG CANCER IN HIGH-RISK OBESE INDIVIDUALS

Principal Investigator: Yendamuri, Sai

A Phase I/II Basket Trial of the EGF Vaccine CIMAvax in Combination with the Anti-PD1 Therapy in Patients with Advanced NSCLC or Squamous Head and Neck Cancer

Principal Investigator: Jain, Prantesh

A Feasibility and Toxicity Analysis of Single Fraction Stereotactic Body Radiation Therapy for Post-Operative Non-Small Cell Lung Cancer

Principal Investigator: Singh, Anurag K

A Phase 0 Study of CIMAvax-EGF vaccine in Patients Who Are At High Risk for Lung Cancer and Lung Cancer Survivors at Risk for Recurrence

Principal Investigator: Reid, Mary E

A Phase II Trial of Lamivudine in Combination with Chemoimmunotherapy in Patients with Extensive Stage SCLC

Principal Investigator: Dy, Grace K

A Phase 1/2 Open-label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Tolerability, and Pharmacokinetics of HPN328 Monotherapy and HPN328 with Atezolizumab in Patients with Advanced Cancers Associated with Expression of Delta-like…

Principal Investigator: Jain, Prantesh

(A151216) Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

Principal Investigator: Dy, Grace K

Preoperative Respiratory Muscle Training to Prevent Postoperative Pulmonary Complications in Patients Undergoing Resection for Lung Cancer

Principal Investigator: Yendamuri, Sai

Phase I/ II Study of Pulmonary Suffusion to Control Minimal Residual Disease in
Resectable or Ablatable Sarcoma or Colorectal Pulmonary Metastases

Principal Investigator: Demmy, Todd L